Apolipoprotein M could inhibit growth and metastasis of SMMC7721 cells via vitamin D receptor signaling

References

• Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87–108. doi:10.3322/caac.2126225651787
   PubMed Web of Science ®Google Scholar
• Singh AK, Kumar R, Pandey AK. Hepatocellular carcinoma: causes, mechanism of progression and biomarkers. Curr Chem Genom Transl Med. 2018;12:9–26. doi:10.2174/221398850181201000930069430
   PubMedGoogle Scholar
• Nemes K, Aberg F, Gylling H, Isoniemi H. Cholesterol metabolism in cholestatic liver disease and liver transplantation: from molecular mechanisms to clinical implications. World J Hepatol. 2016;8(22):924–932. doi:10.4254/wjh.v8.i22.92427574546
   PubMedGoogle Scholar
• Jiang JT, Xu N, Zhang XY, Wu CP. Lipids changes in liver cancer. J Zhejiang Univ Sci B. 2007;8(6):398–409. doi:10.1631/jzus.2007.B083117565510
   PubMedGoogle Scholar
• Xu N, Dahlback B. A novel human apolipoprotein (apoM). J Biol Chem. 1999;274(44):31286–31290. doi:10.1074/jbc.274.44.3128610531326
   PubMed Web of Science ®Google Scholar
• Huang LZ, Gao JL, Pu C, et al. Apolipoprotein M: research progress, regulation and metabolic functions (Review). Mol Med Rep. 2015;12(2):1617–1624. doi:10.3892/mmr.2015.365825901639
   PubMed Web of Science ®Google Scholar
• Ren K, Tang ZL, Jiang Y, Tan YM, Yi GH. Apolipoprotein M. Clin Chim Acta. 2015;446:21–29. doi:10.1016/j.cca.2015.03.03825858547
   PubMed Web of Science ®Google Scholar
• Luo G, Zhang X, Mu Q, et al. Expression and localization of apolipoprotein M in human colorectal tissues. Lipids Health Dis. 2010;9:102. doi:10.1186/1476-511X-9-10220846402
   PubMed Web of Science ®Google Scholar
• Yu MM, Yao S, Luo KM, et al. Apolipoprotein M increases the expression of vitamin D receptor mRNA in colorectal cancer cells detected with duplex fluorescence reverse transcription-quantitative polymerase chain reaction. Mol Med Rep. 2017;16(2):1167–1172. doi:10.3892/mmr.2017.671629067439
   PubMed Web of Science ®Google Scholar
• Jiang J, Wu C, Luo G, et al. Expression of apolipoprotein M in human hepatocellular carcinoma tissues. Acta Histochem. 2011;113(1):53–57. doi:10.1016/j.acthis.2009.08.00519796793
   PubMed Web of Science ®Google Scholar
• Gonzalez-Parra E, Rojas-Rivera J, Tunon J, Praga M, Ortiz A, Egido J. Vitamin D receptor activation and cardiovascular disease. Nephrol Dial Transplant. 2012;27(Suppl 4):iv17–21. doi:10.1093/ndt/gfs53423258805
   PubMedGoogle Scholar
• Christakos S, Dhawan P, Verstuyf A, Verlinden L, Carmeliet G. Vitamin D: metabolism, molecular mechanism of action, and pleiotropic effects. Physiol Rev. 2016;96(1):365–408. doi:10.1152/physrev.00014.201526681795
   PubMed Web of Science ®Google Scholar
• Campbell MJ, Trump DL. Vitamin D receptor signaling and cancer. Endocrinol Metab Clin North Am. 2017;46(4):1009–1038. doi:10.1016/j.ecl.2017.07.00729080633
   PubMed Web of Science ®Google Scholar
• Jeon SM, Shin EA. Exploring vitamin D metabolism and function in cancer. Exp Mol Med. 2018;50(4):20. doi:10.1038/s12276-018-0038-929657326
   PubMedGoogle Scholar
• Cicognani C, Malavolti M, Morselli-Labate AM, Zamboni L, Sama C, Barbara L. Serum lipid and lipoprotein patterns in patients with liver cirrhosis and chronic active hepatitis. Arch Intern Med. 1997;157(7):792–796.9125012
   PubMedGoogle Scholar
• Swenson ES, Guest I, Ilic Z, et al. Hepatocyte nuclear factor-1 as marker of epithelial phenotype reveals marrow-derived hepatocytes, but not duct cells, after liver injury in mice. Stem Cells. 2008;26(7):1768–1777. doi:10.1634/stemcells.2008-014818467658
   PubMed Web of Science ®Google Scholar
• Richter S, Shih DQ, Pearson ER, et al. Regulation of apolipoprotein M gene expression by MODY3 gene hepatocyte nuclear factor-1alpha: haploinsufficiency is associated with reduced serum apolipoprotein M levels. Diabetes. 2003;52(12):2989–2995. doi:10.2337/diabetes.52.12.298914633861
   PubMed Web of Science ®Google Scholar
• Ma X, Hu YW, Zhao ZL, et al. Anti-inflammatory effects of propofol are mediated by apolipoprotein M in a hepatocyte nuclear factor-1alpha-dependent manner. Arch Biochem Biophys. 2013;533(1–2):1–10. doi:10.1016/j.abb.2013.03.00223500137
   PubMed Web of Science ®Google Scholar
• Ding CH, Deng LF, Chen F, et al. p.Q511L mutation of HNF1alpha in hepatocellular carcinoma suppresses the transcriptional activity and the anti-tumor effect of HNF1alpha. Biochem Biophys Res Commun. 2018;495(1):86–91. doi:10.1016/j.bbrc.2017.10.17429101032
   PubMed Web of Science ®Google Scholar
• Ji T, Li G, Chen J, et al. Distinct role of interleukin-6 and tumor necrosis factor receptor-1 in oval cell- mediated liver regeneration and inflammation-associated hepatocarcinogenesis. Oncotarget. 2016;7(41):66635–66646. doi:10.18632/oncotarget.1136527556180
   PubMedGoogle Scholar
• Zhu XW, Gong JP. Expression and role of icam-1 in the occurrence and development of hepatocellular carcinoma. Asian Pac J Cancer Prev. 2013;14(3):1579–1583. doi:10.7314/APJCP.2013.14.3.157923679239
   PubMedGoogle Scholar
• Abdalla M, Khairy E, Louka ML, Ali-Labib R, Ibrahim EA. Vitamin D receptor gene methylation in hepatocellular carcinoma. Gene. 2018;653:65–71. doi:10.1016/j.gene.2018.02.02429432829
   PubMed Web of Science ®Google Scholar
• Horvath E, Balla B, Kosa J, et al. [Vitamin D metabolism and signaling in human hepatocellular carcinoma and surrounding non-tumorous liver]. Orv Hetil. 2016;157(48):1910–1918.27889974
   PubMed Web of Science ®Google Scholar
• Wang Q, Gao G, Zhang T, et al. TRAF1 is critical for regulating the BRAF/MEK/ERK pathway in non-small cell lung carcinogenesis. Cancer Res. 2018;78(14):3982–3994. doi:10.1158/0008-5472.CAN-18-042929748372
   PubMed Web of Science ®Google Scholar
• Chen R, Xia W, Wang X, et al. Upregulated long non-coding RNA SBF2-AS1 promotes proliferation in esophageal squamous cell carcinoma. Oncol Lett. 2018;15(4):5071–5080.29552140
   PubMed Web of Science ®Google Scholar
• Lv J, Qiu M, Xia W, et al. High expression of long non-coding RNA SBF2-AS1 promotes proliferation in non-small cell lung cancer. J Exp Clin Cancer Res. 2016;35:75. doi:10.1186/s13046-016-0444-627154193
   PubMed Web of Science ®Google Scholar
• Wang M, Luo GH, Liu H, et al. Apolipoprotein M induces inhibition of inflammatory responses via the S1PR1 and DHCR24 pathways. Mol Med Rep. 2019;19(2):1272–1283.30569161
   PubMed Web of Science ®Google Scholar
• Blaho VA, Galvani S, Engelbrecht E, et al. HDL-bound sphingosine-1-phosphate restrains lymphopoiesis and neuroinflammation. Nature. 2015;523(7560):342–346. doi:10.1038/nature1446226053123
   PubMed Web of Science ®Google Scholar
• Hajny S, Christoffersen C, Novel A. Perspective on the ApoM-S1P axis, highlighting the metabolism of ApoM and its role in liver fibrosis and neuroinflammation. Int J Mol Sci. 2017;18(8). doi:10.3390/ijms18081636
   PubMed Web of Science ®Google Scholar
• Shin K, Kim KP, Cho Y, et al. Both sphingosine kinase 1 and 2 coordinately regulate cathelicidin antimicrobial peptide production during keratinocyte differentiation. J Invest Dermatol. 2019;139(2):492–494. doi:10.1016/j.jid.2018.08.01530227139
   PubMed Web of Science ®Google Scholar
• Sun J, Kong J, Duan Y, et al. Increased NF-kappaB activity in fibroblasts lacking the vitamin D receptor. Am J Physiol Endocrinol Metab. 2006;291(2):E315–322. doi:10.1152/ajpendo.00359.200516507601
   PubMed Web of Science ®Google Scholar
• Chen Y, Zhang J, Ge X, Du J, Deb DK, Li YC. Vitamin D receptor inhibits nuclear factor kappaB activation by interacting with IkappaB kinase beta protein. J Biol Chem. 2013;288(27):19450–19458. doi:10.1074/jbc.M113.46767023671281
   PubMed Web of Science ®Google Scholar
• Khammissa RAG, Fourie J, Motswaledi MH, Ballyram R, Lemmer J, The Biological FL. Activities of vitamin D and its receptor in relation to calcium and bone homeostasis, cancer, immune and cardiovascular systems, skin biology, and oral health. Biomed Res Int. 2018;2018:9276380. doi:10.1155/2018/927638029951549
   PubMed Web of Science ®Google Scholar
• Chen Y, Liu X, Zhang F, et al. Vitamin D receptor suppresses proliferation and metastasis in renal cell carcinoma cell lines via regulating the expression of the epithelial Ca2+ channel TRPV5. PLoS One. 2018;13(4):e0195844. doi:10.1371/journal.pone.019584429659618
   PubMed Web of Science ®Google Scholar
• Rosen CJ, Adams JS, Bikle DD, et al. The nonskeletal effects of vitamin D: an endocrine society scientific statement. Endocr Rev. 2012;33(3):456–492. doi:10.1210/er.2012-100022596255
   PubMed Web of Science ®Google Scholar
• Dimitrov V, Salehi-Tabar R, An BS, White JH. Non-classical mechanisms of transcriptional regulation by the vitamin D receptor: insights into calcium homeostasis, immune system regulation and cancer chemoprevention. J Steroid Biochem Mol Biol. 2014;144(Pt A):74–80. doi:10.1016/j.jsbmb.2013.07.01223911725
   PubMedGoogle Scholar